托珠单抗治疗新型冠状病毒肺炎 - Suppr

Suppr

超能文献

Tocilizumab in Covid-19.

作者信息

Leaf David E, Gupta Shruti, Wang Wei

机构信息

Brigham and Women's Hospital, Boston, MA

出版信息

N Engl J Med. 2021 Jan 7;384(1):86-87. doi: 10.1056/NEJMc2032911. Epub 2020 Dec 22.

DOI:10.1056/NEJMc2032911

PMID:33356049

Abstract

摘要

相似文献

Tocilizumab in Covid-19.

N Engl J Med. 2021 Jan 7;384(1):86-87. doi: 10.1056/NEJMc2032911. Epub 2020 Dec 22.

Tocilizumab in Covid-19. Reply.

N Engl J Med. 2021 Jan 7;384(1):87. doi: 10.1056/NEJMc2032911. Epub 2020 Dec 22.

Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.

Transpl Infect Dis. 2020 Aug;22(4):e13326. doi: 10.1111/tid.13326. Epub 2020 Jun 5.

Lack of tocilizumab effect on mortality in COVID19 patients.

Sci Rep. 2020 Oct 13;10(1):17100. doi: 10.1038/s41598-020-74328-x.

Cytokine Storm Drugs Move from CAR T to COVID-19.

Cancer Discov. 2020 Jul;10(7):OF8. doi: 10.1158/2159-8290.CD-ND2020-008. Epub 2020 May 5.

Covid-19 controversies: the tocilizumab chapter.

BMJ. 2021 Jan 27;372:n244. doi: 10.1136/bmj.n244.

Tocilizumab, blood cells, and mild COVID-19: delayed vascular protection by interleukin blockade?

Eur Heart J Cardiovasc Pharmacother. 2021 Sep 21;7(5):e81-e82. doi: 10.1093/ehjcvp/pvab051.

Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors' reply.

Pulmonology. 2021 Jan-Feb;27(1):87-88. doi: 10.1016/j.pulmoe.2020.10.003. Epub 2020 Oct 21.

Tocilizumab for COVID-19: a real 'miracle drug'?

Infect Dis (Lond). 2020 Sep;52(9):681-682. doi: 10.1080/23744235.2020.1780307. Epub 2020 Jun 17.

Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma.

Br J Haematol. 2020 Jul;190(1):e9-e11. doi: 10.1111/bjh.16787. Epub 2020 May 18.

引用本文的文献

Determination of Serum Levels of Interleukin-6 and the Trace Element Zinc According to the Clinical Status of Patients With COVID-19.

Interdiscip Perspect Infect Dis. 2025 Jun 12;2025:6486467. doi: 10.1155/ipid/6486467. eCollection 2025.

Mucosal implications of oral Jak3-targeted drugs in COVID patients.

Mol Med. 2025 May 23;31(1):203. doi: 10.1186/s10020-025-01260-z.

The role of SARS-COV-2 infection in promoting abnormal immune response and sepsis: A comparison between SARS-COV-2-related sepsis and sepsis from other causes.

Infect Med (Beijing). 2023 Apr 28;2(3):202-211. doi: 10.1016/j.imj.2023.04.006. eCollection 2023 Sep.

What is the aetiology of dysnatraemia in COVID-19 and how is this related to outcomes in patients admitted during earlier and later COVID-19 waves? A multicentre, retrospective observational study in 11 Dutch hospitals.

BMJ Open. 2023 Nov 14;13(11):e075232. doi: 10.1136/bmjopen-2023-075232.

New Advances in Viral and Microorganism Disinfectants.

Microorganisms. 2023 Oct 10;11(10):2530. doi: 10.3390/microorganisms11102530.

Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.

Life (Basel). 2023 Aug 16;13(8):1752. doi: 10.3390/life13081752.

Development and external validation of a prediction model for the transition from mild to moderate or severe form of COVID-19.

Eur Radiol. 2023 Dec;33(12):9262-9274. doi: 10.1007/s00330-023-09759-x. Epub 2023 Jul 5.

Molecular and therapeutic effect of CRISPR in treating cancer.

Med Oncol. 2023 Jan 17;40(2):81. doi: 10.1007/s12032-022-01930-6.

Therapeutic advances in COVID-19.

Nat Rev Nephrol. 2023 Jan;19(1):38-52. doi: 10.1038/s41581-022-00642-4. Epub 2022 Oct 17.

Hyper-inflammatory responses in COVID-19 and anti-inflammatory therapeutic approaches.

BMB Rep. 2022 Jan;55(1):11-19. doi: 10.5483/BMBRep.2022.55.1.152.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验